Head-to-head comparison
Boston Medical Group vs Renlo Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Boston Medical Group is an established medical group running a 12-week compounded GLP-1 weight-loss program.
From $199/mo (lowest dose rung) sema · Verified August 2026
Marked down on: The published rate is a range by dose strength, $199 to $299, so the figure quoted is the floor rather than what a titrated patient pays
Desk Score
One of the few programs whose headline is the actual monthly rate, with the prescribing physician and the dispensing pharmacy both named.
$199/mo (see conditions) sema · $269/mo (see conditions) tirz · Verified September 2026
Marked down on: A struck-through $399 sits beside the price with no published basis — Renlo never says what it was, when it applied or to whom.
Renlo Health takes this head-to-head with the higher Desk Score, 80/100 (B−) against 67/100 (C) for Boston Medical Group. Boston Medical Group still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Boston Medical Group
67/100
C
Renlo Health
80/100
B−
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Boston Medical Group | Renlo Health |
|---|---|---|
| Semaglutide | From $199/molowest dose rung$199/mo (starting strength, rising with dose, compounded) | $199/mosee conditions$199/mo (compounded, billed monthly at every dose) |
| Tirzepatide | Not listed on Boston Medical Group's site (checked August 2026) | $269/mosee conditions$269/mo (compounded, billed monthly at every dose) |
| Coverage | 7 states | Not listed on Renlo Health's site (checked September 2026) |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | People who want a clinician-run 12-week program and can accept a price quoted as a range rather than a rate. | Someone who wants a flat monthly bill, a named prescriber and a refund route, and can ignore an anchor nobody explains. |
| Desk Score | 67/100C | 80/100B− |
The verdict
Desk pick — Renlo HealthRenlo Health takes this head-to-head with the higher Desk Score, 80/100 (B−) against 67/100 (C) for Boston Medical Group. Boston Medical Group still holds its ground where its strengths line up with yours.
Choose Boston Medical Group if…
People who want a clinician-run 12-week program and can accept a price quoted as a range rather than a rate.
From $199/mo (lowest dose rung) sema · 7 states
Choose Renlo Health if…
Someone who wants a flat monthly bill, a named prescriber and a refund route, and can ignore an anchor nobody explains.
$199/mo (see conditions) sema · $269/mo (see conditions) tirz
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Boston Medical Group · Renlo Health.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- Boston Medical Group vs CoreAge Rx
- CoreAge Rx vs Renlo Health
- Boston Medical Group vs HealthRX
- HealthRX vs Renlo Health
- Boston Medical Group vs RestorLife Med
- Renlo Health vs Welling Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.